Outcomes For Cervical Cancer Patients Treated With Extended Field Intensity Modulated Radiation Therapy And Concurrent Cisplatin

被引：2
|
作者：
Jensen, L. [1 ]
Hasselle, M. D. [2 ]
Rose, B. S. [1 ]
Nath, S. K. [1 ]
Hasan, Y. [2 ]
Yashar, C. M. [1 ]
Mundt, A. J. [1 ]
Mell, L. K. [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.970
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S452 / S453
页数：2
相关论文
共 50 条
  • [1] Outcomes for Patients With Cervical Cancer Treated With Extended-Field Intensity-Modulated Radiation Therapy and Concurrent Cisplatin
    Jensen, Lindsay G.
    Hasselle, Michael D.
    Rose, Brent S.
    Nath, Sameer K.
    Hasan, Yasmin
    Scanderbeg, Dan J.
    Yashar, Catheryn M.
    Mundt, Arno J.
    Mell, Loren K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (01) : 119 - 125
  • [2] Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiation therapy
    Mell, LK
    Kochanski, J
    Roeske, J
    Rash, C
    Kubisch, R
    Mundt, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S96 - S97
  • [3] Outcome of cervical cancer patients treated with intensity modulated radiation therapy
    Kochanski, JD
    Mehta, N
    Mell, LK
    Roeske, JC
    Sutton, H
    Mundt, AJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S214 - S214
  • [4] Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer
    Sood, BM
    Timmins, PF
    Gorla, GR
    Garg, M
    Anderson, PS
    Vikram, B
    Goldberg, GL
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (05) : 459 - 464
  • [5] Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity modulated radiotherapy for carcinoma of the cervix
    Colonello, K
    Gerszten, K
    Heron, DE
    Fitian, I
    Comerci, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S301 - S302
  • [6] The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy
    Chen, Chien-Chih
    Wang, Lily
    Lin, Jin-Ching
    Jan, Jian-Sheng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (03) : 231 - 237
  • [7] Comparison of intensity modulated radiation therapy (IMRT) with conventional radiotherapy (CRT) for cervical cancer with concurrent cisplatin (CDDP)
    Thawani, N.
    Vainshtein, J. M.
    Hannan, R.
    Kalnicki, S.
    Yaparpalvi, R.
    Mutyala, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Adjuvant Intensity Modulated Radiation Therapy With Concurrent Paclitaxel and Cisplatin in Cervical Cancer Patients With High Risk Factors: A Phase 2 Trial
    Wang, X.
    Shen, Y.
    Zhao, Y.
    Li, Z.
    Xu, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S8 - S8
  • [9] Comparison of Outcomes for Cervical Cancer Patients Treated With Radiation and Concurrent Weekly Cisplatin Versus Cisplatin and 5-Fluorouracil
    Kidd, E. A.
    Roux, A.
    von Eyben, R.
    Teng, N. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S475 - S475
  • [10] Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix
    Gerszten, Kristina
    Colonello, Kelly
    Heron, Dwight E.
    Lalonde, Ron J.
    Fitian, Issa D.
    Comerci, John T.
    Selvaraj, Raj N.
    Varlotto, John M.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (02) : 182 - 188
12345